They may believe this is more likely to be accepted because the vaccine technology is a familiar and longstanding one. But it reads to me as a hard sell, and may be the result of the company being inexperienced at regulatory affairs. Either way, it remains true what they say about 100% of the shots you don’t take.
Apparently, an EUA application has already been submitted for the Bharat vaccine for ages 2-18 (see: https://ir.ocugen.com/news-releases/news-release-details/ocugen-inc-announces-submission-emergency-use-authorization). The pediatric trial included just 526 kids. Not sure what they're thinking here -- I can't imagine the FDA supporting it.
They may believe this is more likely to be accepted because the vaccine technology is a familiar and longstanding one. But it reads to me as a hard sell, and may be the result of the company being inexperienced at regulatory affairs. Either way, it remains true what they say about 100% of the shots you don’t take.
THANK YOU for the quick and useful response to my query! <SMILE>
Happy to help!